Clinical Trial Update: Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing

View source ↗

Summary

Clinical trial update detailing the molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing, based on completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Erythroid Leukemia

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Acute Myeloid Leukemia | Status: COMPLETED